Identification of synthetic vaccine candidates against SARS CoV infection

Shu Pei Lien, Yi Ping Shih, Hsin Wei Chen, Jy Ping Tsai, Chih Hsiang Leng, Min Han Lin, Li Hsiu Lin, Hsin Yu Liu, Ai Hsiang Chou, Yu Wen Chang, Yi Ming A. Chen, Pele Chong, Shih Jen Liu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Three peptides, D1 (amino acid residues 175-201), D2 (a.a. 434-467), and TM (a.a. 1128-1159), corresponding to the spike protein (S) of severe acute respiratory syndrome corona virus (SARS CoV) were synthesized and their immunological functions were investigated in three different animals models (mice, guinea pigs, and rabbits). The peptides mixture formulated either with Freund's adjuvant or synthetic adjuvant Montanide ISA-51/oligodeoxy nucleotide CpG (ISA/CpG) could elicit antisera in immunized animals which were capable of inhibiting SARS/HIV pseudovirus entry into HepG2 cells. The neutralizing epitopes were identified using peptides to block the neutralizing effect of guinea pig antisera. The major neutralizing epitope was located on the D2 peptide, and the amino acid residue was fine mapped to 434-453. In BALB/c mice T-cell proliferation assay revealed that only D2 peptide contained T-cell epitope, the sequence of which corresponded to amino acid residue 434-448. The ISA/CpG formulation generated anti-D2 IgG titer comparable to those obtained from Freund's adjuvant formulation, but generated fewer antibodies against D1 or TM peptides. The highly immunogenic D2 peptide contains both neutralizing and Th cell epitopes. These results suggest that synthetic peptide D2 would be useful as a component of SARS vaccine candidates.

Original languageEnglish
Pages (from-to)716-721
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume358
Issue number3
DOIs
Publication statusPublished - Jul 6 2007
Externally publishedYes

Fingerprint

SARS Virus
Synthetic Vaccines
Virus Diseases
Viruses
Peptides
Epitopes
Freund's Adjuvant
Amino Acids
Immune Sera
Guinea Pigs
Nucleotides
Animals
Peptide T
T-Lymphocyte Epitopes
Protein S
Hep G2 Cells
T-cells
Cell proliferation
Vaccines
Animal Models

Keywords

  • Epitopes
  • Peptide
  • Pseudovirus
  • SARS CoV
  • Spike protein
  • Vaccine

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lien, S. P., Shih, Y. P., Chen, H. W., Tsai, J. P., Leng, C. H., Lin, M. H., ... Liu, S. J. (2007). Identification of synthetic vaccine candidates against SARS CoV infection. Biochemical and Biophysical Research Communications, 358(3), 716-721. https://doi.org/10.1016/j.bbrc.2007.04.164

Identification of synthetic vaccine candidates against SARS CoV infection. / Lien, Shu Pei; Shih, Yi Ping; Chen, Hsin Wei; Tsai, Jy Ping; Leng, Chih Hsiang; Lin, Min Han; Lin, Li Hsiu; Liu, Hsin Yu; Chou, Ai Hsiang; Chang, Yu Wen; Chen, Yi Ming A.; Chong, Pele; Liu, Shih Jen.

In: Biochemical and Biophysical Research Communications, Vol. 358, No. 3, 06.07.2007, p. 716-721.

Research output: Contribution to journalArticle

Lien, SP, Shih, YP, Chen, HW, Tsai, JP, Leng, CH, Lin, MH, Lin, LH, Liu, HY, Chou, AH, Chang, YW, Chen, YMA, Chong, P & Liu, SJ 2007, 'Identification of synthetic vaccine candidates against SARS CoV infection', Biochemical and Biophysical Research Communications, vol. 358, no. 3, pp. 716-721. https://doi.org/10.1016/j.bbrc.2007.04.164
Lien, Shu Pei ; Shih, Yi Ping ; Chen, Hsin Wei ; Tsai, Jy Ping ; Leng, Chih Hsiang ; Lin, Min Han ; Lin, Li Hsiu ; Liu, Hsin Yu ; Chou, Ai Hsiang ; Chang, Yu Wen ; Chen, Yi Ming A. ; Chong, Pele ; Liu, Shih Jen. / Identification of synthetic vaccine candidates against SARS CoV infection. In: Biochemical and Biophysical Research Communications. 2007 ; Vol. 358, No. 3. pp. 716-721.
@article{a74f8ccb9a294a5db1e9b6bf64175103,
title = "Identification of synthetic vaccine candidates against SARS CoV infection",
abstract = "Three peptides, D1 (amino acid residues 175-201), D2 (a.a. 434-467), and TM (a.a. 1128-1159), corresponding to the spike protein (S) of severe acute respiratory syndrome corona virus (SARS CoV) were synthesized and their immunological functions were investigated in three different animals models (mice, guinea pigs, and rabbits). The peptides mixture formulated either with Freund's adjuvant or synthetic adjuvant Montanide ISA-51/oligodeoxy nucleotide CpG (ISA/CpG) could elicit antisera in immunized animals which were capable of inhibiting SARS/HIV pseudovirus entry into HepG2 cells. The neutralizing epitopes were identified using peptides to block the neutralizing effect of guinea pig antisera. The major neutralizing epitope was located on the D2 peptide, and the amino acid residue was fine mapped to 434-453. In BALB/c mice T-cell proliferation assay revealed that only D2 peptide contained T-cell epitope, the sequence of which corresponded to amino acid residue 434-448. The ISA/CpG formulation generated anti-D2 IgG titer comparable to those obtained from Freund's adjuvant formulation, but generated fewer antibodies against D1 or TM peptides. The highly immunogenic D2 peptide contains both neutralizing and Th cell epitopes. These results suggest that synthetic peptide D2 would be useful as a component of SARS vaccine candidates.",
keywords = "Epitopes, Peptide, Pseudovirus, SARS CoV, Spike protein, Vaccine",
author = "Lien, {Shu Pei} and Shih, {Yi Ping} and Chen, {Hsin Wei} and Tsai, {Jy Ping} and Leng, {Chih Hsiang} and Lin, {Min Han} and Lin, {Li Hsiu} and Liu, {Hsin Yu} and Chou, {Ai Hsiang} and Chang, {Yu Wen} and Chen, {Yi Ming A.} and Pele Chong and Liu, {Shih Jen}",
year = "2007",
month = "7",
day = "6",
doi = "10.1016/j.bbrc.2007.04.164",
language = "English",
volume = "358",
pages = "716--721",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
number = "3",

}

TY - JOUR

T1 - Identification of synthetic vaccine candidates against SARS CoV infection

AU - Lien, Shu Pei

AU - Shih, Yi Ping

AU - Chen, Hsin Wei

AU - Tsai, Jy Ping

AU - Leng, Chih Hsiang

AU - Lin, Min Han

AU - Lin, Li Hsiu

AU - Liu, Hsin Yu

AU - Chou, Ai Hsiang

AU - Chang, Yu Wen

AU - Chen, Yi Ming A.

AU - Chong, Pele

AU - Liu, Shih Jen

PY - 2007/7/6

Y1 - 2007/7/6

N2 - Three peptides, D1 (amino acid residues 175-201), D2 (a.a. 434-467), and TM (a.a. 1128-1159), corresponding to the spike protein (S) of severe acute respiratory syndrome corona virus (SARS CoV) were synthesized and their immunological functions were investigated in three different animals models (mice, guinea pigs, and rabbits). The peptides mixture formulated either with Freund's adjuvant or synthetic adjuvant Montanide ISA-51/oligodeoxy nucleotide CpG (ISA/CpG) could elicit antisera in immunized animals which were capable of inhibiting SARS/HIV pseudovirus entry into HepG2 cells. The neutralizing epitopes were identified using peptides to block the neutralizing effect of guinea pig antisera. The major neutralizing epitope was located on the D2 peptide, and the amino acid residue was fine mapped to 434-453. In BALB/c mice T-cell proliferation assay revealed that only D2 peptide contained T-cell epitope, the sequence of which corresponded to amino acid residue 434-448. The ISA/CpG formulation generated anti-D2 IgG titer comparable to those obtained from Freund's adjuvant formulation, but generated fewer antibodies against D1 or TM peptides. The highly immunogenic D2 peptide contains both neutralizing and Th cell epitopes. These results suggest that synthetic peptide D2 would be useful as a component of SARS vaccine candidates.

AB - Three peptides, D1 (amino acid residues 175-201), D2 (a.a. 434-467), and TM (a.a. 1128-1159), corresponding to the spike protein (S) of severe acute respiratory syndrome corona virus (SARS CoV) were synthesized and their immunological functions were investigated in three different animals models (mice, guinea pigs, and rabbits). The peptides mixture formulated either with Freund's adjuvant or synthetic adjuvant Montanide ISA-51/oligodeoxy nucleotide CpG (ISA/CpG) could elicit antisera in immunized animals which were capable of inhibiting SARS/HIV pseudovirus entry into HepG2 cells. The neutralizing epitopes were identified using peptides to block the neutralizing effect of guinea pig antisera. The major neutralizing epitope was located on the D2 peptide, and the amino acid residue was fine mapped to 434-453. In BALB/c mice T-cell proliferation assay revealed that only D2 peptide contained T-cell epitope, the sequence of which corresponded to amino acid residue 434-448. The ISA/CpG formulation generated anti-D2 IgG titer comparable to those obtained from Freund's adjuvant formulation, but generated fewer antibodies against D1 or TM peptides. The highly immunogenic D2 peptide contains both neutralizing and Th cell epitopes. These results suggest that synthetic peptide D2 would be useful as a component of SARS vaccine candidates.

KW - Epitopes

KW - Peptide

KW - Pseudovirus

KW - SARS CoV

KW - Spike protein

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=34248993523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248993523&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2007.04.164

DO - 10.1016/j.bbrc.2007.04.164

M3 - Article

VL - 358

SP - 716

EP - 721

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -